Payment & Shipping Terms:
|Reship Policy:||Free Policy||Package:||Discreet Ways Of Packing For Customs Pass Guaranteed|
99.5% Purity Raw Steroid Powders Formestanes Lentaron For Cancer Treatment CAS 566-48-3
Other name: Lentarons; FORMESTAQNEs; Hydroxyandrostenediones
CAS Registry Number: 566-48-3
Assay: 98%Packing: 1kg/aluminum foil bag
Molecular Formula: C19H26O3
Molecular Weight: 302.41
Appearance: White crystalline powder
A. Formestanes is a synthetic steroidal substance with antineoplastic activity. Formestanes binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens.
B. Formestanes is a drug that has been previously used in breast cancer treatment. Like most drugs which have some sort of phsyique usage, athletes eventually get a hold of it. Formestanes is currently one of the best legal anti-estrogens out there. It is classified as an irreversible arromatase inhibitor, meaning, it destroys the aromatase enzyme.
C. Formestanes is often used to suppress estrogen production from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a mild aromatase inhibitor.
Formestanes has poor oral bioavailability and as such is no longer popular as many orally active aromatase inhibitors have been identified.
Formestanes is a second generation, irreversible, steroidal aromatase inhibitor. It inhibits the aromatase enzyme responsible for converting androgens to estrogens, thereby preventing estrogen production. Breast cancer may be estrogen sensitive or insensitive. A majority of breast cancers are estrogen sensitive. Estrogen sensitive breast cancer cells depend on estrogen for viability. Thus removal of estrogen from the body can be an effective treatment for hormone sensitive breast cancers. Formestanes has been targeted specifically for the treatment of postmenopausal women. Unlike premenopausal women who produce most estrogen in the ovaries, postmenopausal women produce most estrogen in peripheral tissues with the help of the aromatase enzyme. Formestanes, an aromatase inhibitor, can thus help to decrease the local production of estrogen by blocking the aromatase enzyme in peripheral tissues (ie. Adispose tissue of the breast) to treat hormone sensitive breast cancer.
|Appearance||White crystalline powder|
|Chromatographic purity||Any individual impurity not more than 1.0%
Total impurities not more than 2.0%
|Loss on drying||Not more than 0.5%||0.1%|
|Residue on ignition||Not more than 0.2%||0.1%|
Not detect out
Not detect out
Not detect out
|Assay||Between 97.0% and 102.0%||99.2%|
|Micronixation||90% not more than 10 microns||90% not more than 10 aicrons|